Have an account?
Log in to check out faster.
Loading...
May, 2024
June, 2024
Learn why you should start your probiotics journey with Bio-K+
Our scientifically proven formulas are designed to support your unique health journey
The safety of probiotics during pregnancy is one of the most searched questions in prenatal wellness, and the consensus from published research is clear: prenatal probiotic safety is well-supported for healthy individuals, with Lactobacillus and Bifidobacterium species among the most widely evaluated genera in randomized controlled trials and meta-analyses. Probiotics during pregnancy are generally considered safe, and the most important first step before starting any new product is to consult your healthcare practitioner. This is the standard recommended position across every major Canadian and international health authority, and it applies regardless of format, brand, or strain.
Not all probiotic strains have the same evidence base for pregnancy-safe use. Strain identity is the deciding factor: a label listing only a genus name without a strain code offers no clinical certainty. Bio-K+ Women's Health Capsules contain Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™, the world's most documented probiotics combination for women's urogenital health.
Probiotic strains studied in pregnancy include this specific pair; they have been tested in diverse populations of women, including pregnant women, with no serious adverse events reported. Their research history spans more than 20 years, 60+ scientific publications, and more than 25 clinical trials. GR-1™ was isolated from the distal urethra of a healthy woman in 1980; RC-14™ from the vagina of a healthy woman in 1985. Their origins are directly relevant to their urogenital research history.
Choosing a pregnancy-appropriate probiotic in Canada involves knowing what to look for on the label. Four criteria matter most. First, strain codes should appear in full: GR-1™ and RC-14™, not simply Lactobacillus rhamnosus. Second, the CFU count should be guaranteed until the expiry date, not only at manufacture. Third, a Health Canada Natural Product Number on the label confirms the product has met Canadian standards for safety, quality, and efficacy review. Fourth, certifications such as gluten-free and non-GMO address common dietary considerations during pregnancy.
Bio-K+ Women's Health Capsules meet all four criteria, with 2 billion CFU guaranteed until the expiry date, no refrigeration required, and the Health Canada-approved claims: "Helps restore and maintain healthy vaginal flora" and "Reduces yeasts and bacteria on vaginal surfaces to maintain feminine health." As always, consult your healthcare practitioner before starting.
Based on the published research, including multiple systematic reviews and meta-analyses, the answer for healthy individuals is generally yes. Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™, the strains in Bio-K+ Women's Health Capsules, have been clinically studied in pregnant women, with no serious adverse events reported. This applies specifically to these strains. Always consult your healthcare practitioner before starting any new product during pregnancy to confirm it is appropriate for you.
Lactobacillus and Bifidobacterium species are the most widely researched genera in pregnancy contexts. Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ are the world's most documented probiotics combination for women's urogenital health, backed by 60+ scientific publications and more than 25 clinical trials. These strains have been clinically studied in pregnant women, with no serious adverse events reported. When evaluating a probiotic for pregnancy, look for fully identified strain codes on the label. Consult your healthcare practitioner for strain-specific guidance appropriate to your situation.
The published research on probiotics in the first trimester and across pregnancy broadly supports their general safety for healthy individuals, based on available systematic reviews. Most clinical trial data for specific strains includes populations studied across the second and third trimesters, though the safety consensus is not trimester-restricted for healthy women. Bio-K+ Women's Health Capsules are intended for adults and adolescents aged 12 and older, with no trimester restrictions. Consult your healthcare practitioner for guidance specific to your trimester and individual health needs.
Reading a probiotic label during pregnancy involves four steps. First, confirm strain codes are listed by name, such as GR-1™ and RC-14™, not just the genus. Second, verify the CFU count is guaranteed until the expiry date, not only at manufacture. Third, look for a Health Canada Natural Product Number, which confirms the product has been reviewed for safety, quality, and efficacy under Canadian standards. Fourth, check certifications such as gluten-free and non-GMO. Discuss your probiotic choice with your healthcare practitioner before starting.
Taking probiotics while pregnant and continuing into the breastfeeding period is addressed in Bio-K+'s existing guide on probiotics for pregnant and breastfeeding moms. Lacticaseibacillus rhamnosus GR-1™ and Limosilactobacillus reuteri RC-14™ in Women's Health Capsules have been clinically studied in various female populations, with no serious adverse events reported. The confirmed label directions apply to adults and adolescents 12 years and older, with no exclusion for breastfeeding. Consult your healthcare practitioner for guidance specific to your individual health situation during breastfeeding.
Follow @biokplus and tag us to be mentioned